Profil
Gary Allenby is the founder and current Chief Executive Officer of Aurelia Bioscience Ltd, which was founded in 2003.
Postes actifs de Gary Allenby
| Sociétés | Poste | Début |
|---|---|---|
Aurelia Bioscience Ltd.
 Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Directeur Général | 01/01/2003 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aurelia Bioscience Ltd.
Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
